Microbot Medical Inc. (NASDAQ:MBOT) does about 166.14K shares in volume on a normal day but saw 1511813 shares change hands in Friday trading. The company now has a market cap of 56.63M USD and an enterprise value of about $21.79M. Its current market price is $8.16, marking an increase of 2.38% compared to the previous close of $7.97. The 52 week high reached by this stock is $20.15 whilst the lowest price level in 52 weeks is $4.30. The script in recent trading has seen the stock touch a high of $9.20 and a low of $7.70.

Microbot Medical Inc. (MBOT) has a 20-day trading average at $6.92 and the current price is -59.50% off the 52-week high compared with 89.77% distance from its 52-week low. The 50-day simple moving average of the closing price is $6.85 and its 200-day simple moving average is $7.27. If we look at the stock’s price movements over the week, volatility stands at 12.32%, which decreases to 6.75% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 68.96 to suggest the stock is neutral.

1 analysts observing the Microbot Medical Inc. (MBOT) stock have set the 12-month price targets for the company’s shares at between $19.00 and $19.00. The median price target is 57.05% away from the current levels at $19.00.

FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Moderate Buy the stock.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on January 13, 2020 when H.C. Wainwright reiterated the stock to “Buy” and issued a price target of between $12 and $26. Ladenburg Thalmann initiated its price target at $1.75.

The current price level is 19.28%, 19.35%, and 12.51% away from its SMA20, SMA50, and SMA200 respectively, with the MBOT price moving below the 50-day SMA on August 14. Microbot Medical Inc. (MBOT) stock is up 17.58% over the week and 28.10% over the past month. Its price is -19.76% year-to-date and 46.24% over the past year.

The stock last released its quarterly earnings report for quarter ended 6/29/2020, with the company’s earnings per share (EPS) of -$0.26 above consensus estimates by $0.01. The company’s next earnings report is expected on 08/18/2020, with forecasts estimating quarterly EPS at -$0.28 and -$1.15 for whole year. MBOT’s earnings per share are forecast to grow by 32.40% this year and -13.00% over next year. In addition, estimates put the company’s current quarterly revenue at an average of $1 million.

Its 12-month price target is $19.00. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $19.00, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $19.00.

Outstanding shares total 7.15M with insiders holding 8.29% of the shares and institutional holders owning 13.32% of the company’s common stock. The company has a return on equity of -39.60%. The beta has a value of 4.36. Price to book ratio is 1.97.

According to a U.S. Securities and Exchange Commission filing, Vanguard Total Stock Market Index has reduced its position in Microbot Medical Inc. (MBOT) to 129,911 shares, mirroring a recent drop by 0.00%. Vanguard Total Stock Market Index dumped 0.0 shares of Microbot Medical Inc. common stock bringing its total worth to about $0.87 million at the end of recent close, SEC documents show. Vanguard Extended Market Index Fu cut their holdings by 0.00% in the company over the course of the most recent quarter. It now holds a 1.32% position in Microbot Medical Inc. thanks to 94041.0 shares amounting to $0.63 million.